|
NCAPD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.230200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.214800E-01 |
| Normal-vs-Stage2 |
9.069200E-01 |
| Normal-vs-Stage3 |
3.140400E-01 |
| Normal-vs-Stage4 |
7.189000E-01 |
| Stage1-vs-Stage2 |
6.835000E-01 |
| Stage1-vs-Stage3 |
9.288100E-02 |
| Stage1-vs-Stage4 |
9.642600E-01 |
| Stage2-vs-Stage3 |
3.845800E-01 |
| Stage2-vs-Stage4 |
7.573200E-01 |
| Stage3-vs-Stage4 |
3.799800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.489000E-01 |
| Normal-vs-AfricanAmerican |
9.584600E-01 |
| Normal-vs-Asian |
6.448000E-01 |
| Caucasian-vs-AfricanAmerican |
8.503800E-01 |
| Caucasian-vs-Asian |
7.719600E-01 |
| AfricanAmerican-vs-Asian |
8.265200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.350200E-02 |
| Normal-vs-Female |
6.436100E-03 |
| Male-vs-Female |
1.786500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.917000E-01 |
| Normal-vs-Extreme_Weight |
4.788000E-02 |
| Normal-vs-Obese |
4.968200E-01 |
| Normal-vs-Extreme_Obese |
6.524200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.206990E-01 |
| Normal_Weight-vs-Obese |
7.730200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.722800E-01 |
| Extreme_Weight-vs-Obese |
3.657700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.326800E-01 |
| Obese-vs-Extreme_Obese |
2.081200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.333820E-01 |
| Normal-vs-Age(41-60Yrs) |
4.793800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.874000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.893800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.855430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.076300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.506000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.827700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.019780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.998400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.009200E-01 |
| Normal-VS-Type2 PRCC |
4.588000E-01 |
| Normal-VS-KIRP CIMP |
9.375500E-02 |
| Normal-VS-Unclassified PRCC |
7.893400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.966000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.150200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.197200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.424200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.469400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.075800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.047000E-01 |
| Normal-vs-N1 |
1.151620E-01 |
| Normal-vs-N2 |
4.920200E-01 |
| N0-vs-N1 |
3.995700E-02 |
| N0-vs-N2 |
6.433800E-01 |
| N1-vs-N2 |
2.513800E-01 |
|
|
